Germany's Chemical Industry Faces Mixed Outlook for 2024-2025
Germany's Chemical Industry Association (VCI) reveals a mixed forecast for 2024 and 2025. While production may rise slightly and pharmaceuticals are expected to see minimal growth, sales and prices are anticipated to decline. COVID-19's effects linger with a potential drop in employment numbers.

The German Chemical Industry Association, VCI, reveals a nuanced outlook for 2024. Production in the industry is set to increase by 2% year-on-year, or 4% excluding pharmaceuticals. However, the total sales figures are anticipated to drop by 2% to EUR 221 billion, with producer prices also falling by 2.5%.
For the coming year, a modest production growth of 0.5% is expected, with pharmaceuticals seeing the same slight increase while the broader chemical sector remains stagnant into 2025. Industry prices could see a minor dip of about 0.5%, with sales predicted to weaken due to rising producer prices and low order backlogs.
The VCI forecasts a potential decline in employment numbers. Despite the challenges, a bright spot remains as certain sectors, like pharmaceuticals, are expected to maintain some growth amid the economic pressures facing the industry.
(With inputs from agencies.)
ALSO READ
Jagsonpal Pharmaceuticals Under Fire: USFDA Raises Alarm
The Role of Radiopharmaceuticals in Modern Medicine: Diagnosis and Treatment
U.S. New Home Sales Decline Amid High Mortgage Rates and Weather Woes
Emcure Pharmaceuticals Faces FDA Observations Post-Pune Facility Inspection
Senores Pharmaceuticals Expands US Market Reach with Major Acquisition